http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Bausch Health Co. Inc. (BHC) And Clearside Biomedical (CLSD) Announce U.S. FDA Filing Acceptance For XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension)
-
Bausch Health And Clearside Biomedical Announce U.S. FDA Filing Acceptance For XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension)
-
Bausch + Lomb and Prevent Blindness Launch Educational Campaign During Cataract Awareness Month
-
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations
-
Bausch Health Announces Participation At The Jefferies Healthcare Conference
-
Salix Will Feature New Data At Digestive Disease Week® 2021
-
Salix Pharmacetuicals Will Present Scientific Data Featuring Post Hoc Analyses For RELISTOR® (Methylnaltrexone Bromide) At ASRA's 46th Annual Spring Meeting
-
New Report Reveals That More Than One-Third Of IBS Patients Surveyed State It Has Been More Challenging To Manage Their Symptoms During The COVID-19 Pandemic
-
Salix Launches GastroHub for Advanced Practice Providers, an Educational Website Designed To Provide Nurse Practitioners and Physician Assistants With Relevant Information for Treating IBS-D and HE
-
Salix Announces 2021 Gastrointestinal Health Scholars Program
-
Prevent Blindness and Bausch + Lomb to Launch Year-Long Video Series to Raise Awareness of Age-Related Macular Degeneration (AMD)
-
Salix To Present Data At AASLD's The Liver Meeting Digital Experience
-
Bausch Health's (BHC) Rifaximin Receives FDA Orphan Designation For Sickle Cell Disease
-
Bausch Health's Rifaximin Receives FDA Orphan Designation For Sickle Cell Disease
-
Salix To Present Data For Products Across Its Portfolio At The American College Of Gastroenterology 2020 Virtual Annual Meeting
-
Salix To Present Clinical Data At United European Gastroenterology Week Virtual 2020
-
Salix Supports Liver Awareness Month With New Educational Initiatives
-
Tesla, Musk sought to 'burn' Citron, other short-sellers: lawsuit
-
US WorldMeds And Salix Pharmaceuticals To Highlight Clinical Data For Opioid Withdrawal Treatment LUCEMYRA™ (lofexidine) At 2018 PAINWeek Conference
-
Bausch Health Co. Inc. (BHC) Subsidiaries, US WorldMeds LLC & Salix Pharma, Report U.S. Launch of LUCEMYRA (lofexidine) 0.18 Mg Tablets
-
US WorldMeds and Salix Announce U.S. Launch of LUCEMYRA™ (lofexidine) 0.18 Mg Tablets

